Literature DB >> 28485638

Endoscopic findings of the gastric mucosa during long-term use of proton pump inhibitor - a multicenter study.

Mariko Kiso1, Masanori Ito1, Tomoyuki Boda2, Takahiro Kotachi1, Kazuhiko Masuda1, Kosaku Hata1, Atsunori Sasaki3, Toru Kawamura4, Masaharu Yoshihara5, Shinji Tanaka2, Kazuaki Chayama1.   

Abstract

BACKGROUND AND AIM: It is clinically important to diagnose drug-induced gastric lesions correctly. Recently, the use of proton pump inhibitors (PPI) has increased worldwide. The histological features induced by PPI have been reported; however, few reports have described endoscopic findings induced by PPI. Therefore, we aimed to clarify the characteristic endoscopic features in PPI users and associated pathogenic factors.
METHODS: We prospectively registered 1007 consecutive participants (70 PPI users and 937 nonusers) who underwent endoscopic examination for cancer screening in three hospitals/clinics. Clinical data and endoscopic findings were recorded in the registration forms. We compared the endoscopic features between the two groups and evaluated contributing factors via univariate and multivariate analyses.
RESULTS: Multiple white elevated lesions (MWEL) and cobblestone-like mucosa (CLM) were more commonly observed in PPI users compared with nonusers (p < .01). Foveolar hyperplastic polyps were also frequently observed in PPI users but were not statistically significantly different (p = .06). MWEL and CLM were more frequently observed in older patients than in younger patients. MWEL was more frequently observed in female patients than in male patients; however, CLM was predominantly observed in male patients.
CONCLUSION: MWEL and CLM are characteristic endoscopic features in PPI users. A gender-associated difference was noted in terms of the frequency of these lesions.

Entities:  

Keywords:  Multiple white elevated lesions; cobblestone-like mucosa; proton pump inhibitor

Mesh:

Substances:

Year:  2017        PMID: 28485638     DOI: 10.1080/00365521.2017.1322137

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  2 in total

1.  Changes in gastric morphology during long-term use of vonoprazan compared to proton pump inhibitors.

Authors:  Satoshi Shinozaki; Hiroyuki Osawa; Yoshikazu Hayashi; Hirotsugu Sakamoto; Yoshimasa Miura; Alan Kawarai Lefor; Hironori Yamamoto
Journal:  Singapore Med J       Date:  2022-05       Impact factor: 3.331

Review 2.  When does proton pump inhibitor treatment become long term? A scoping review.

Authors:  Peter Fentz Haastrup; Dorte Ejg Jarbøl; Wade Thompson; Jane Møller Hansen; Jens Søndergaard; Sanne Rasmussen
Journal:  BMJ Open Gastroenterol       Date:  2021-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.